avatar for Solomon Iyasu

Solomon Iyasu

Merck & Co., Inc.
Vice President and Head of Pharmacoepidemiology
Dr. Iyasu joined Merck and Co. in August of 2015 as head of Pharmacoepidemiology in the Center for Observational and Real-World Evidence (CORE). In his current role, he leads a department that is responsible for designing and conducting postapproval observational safety and effectiveness studies (PASS/PAERs), real-world data analytics to characterize disease epidemiology, inform early development, clinical trial design and endpoint strategy (selection, validation of PROs and clinical outcomes, biomarkers).

My Speakers Sessions

Wednesday, June 26